Aptose Biosciences Inc.
Aptose Biosciences Inc. (APS.TO) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · APS.TO · as of Jun 8, 2026
Key Statistics
Explore Aptose Biosciences Inc. Data
aps.to stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 11 · Buy rate: 90.9%
Competitors & Peers
aps.to competitorsAPS.TO
APLI.TO
AVCR.V
CANB.V
HEAL.CN
KNE.VStock Performance
Full HistoryAbout Aptose Biosciences Inc.
Aptose Biosciences Inc. is a clinical-stage biotechnology firm dedicated to discovering and advancing personalized therapeutic solutions for challenging oncology cases, primarily within the United Sta…
what is aptose biosciences inc. · aps.to stock overview · aptose biosciences inc. company profile · who is aptose biosciences inc. ceo · aps.to TSX · aptose biosciences inc. headquarters · aptose biosciences inc. business segments
About Stock Overview & Key Data
Aptose Biosciences Inc. (APS.TO) is a Healthcare company in the Biotechnology industry, listed on TSX since Apr 25, 1996. As of the latest trading session, APS.TO stock price is $2.20, with a market capitalization of $5.6M. The stock has returned -8.33% over the past 12 months and +3.77% year-to-date.
According to 11 Wall Street analysts, the consensus rating for Aptose Biosciences Inc. stock is Buy, with an average 12-month price target of $—. In fiscal year 2025, Aptose Biosciences Inc. reported revenue of — and net income of -$25.9M. For detailed data — including Aptose Biosciences Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Aptose Biosciences Inc. (APS.TO) stock price is $2.20. The stock is traded on TSX under the ticker symbol APS.TO. The 52-week range is $1.02 – $2.59.